MENU
QURE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
uniQure (QURE) Ownership - Who owns uniQure?
uniQure NV is a gene therapy company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Paasheuvelweg 25
Phone
+31 202406000
Employees
480
Web
https://www.uniqure.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
574.3M
P/E Ratio
N/A
Total Cash
367.52M
Projected Growth
N/A
Total Debt
66.06M
Revenue
27.12M
Risk (Beta)
0.17
Dividend Yield
N/A
Total Cash/Share
6.80
Total Debt/Equity
N/A
Revenue/Share
0.56 USD as % of share price
Fundamentals
QURE
Capitalization
574M
P/E Ratio
N/A
Risk (Beta)
0.17
Dividend Yield
N/A
Total Cash
368M
Total Cash/Share
6.80
Total Debt
66.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.56%
Revenue
27.1M
ROE
N/A
Book Value
-6.75M
P/B Ratio
12.74
Cash Flow
N/A
Earnings
-4.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.95M
Current Ratio
9.74
Current Revenue Per Employee
24980.86
Dividends Per Share - Security
N/A
EBITDA
-160.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.14
Revenue To Assets
-34.51
Shares Held By Institutions
876M
Shares Outstanding - Current
54.1M
Total Liabilities
563M
Total Volume MTD
N/A
Value
-1
Gain YTD
-43.884
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in the discovery, development, and commercialization of gene therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Paasheuvelweg 25
Phone
+31 202406000
Employees
480
Web
https://www.uniqure.com